BCOR/ZC3H12 knockout CD19-targeting CAR-T cell therapy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BCOR/ZC3H12 knockout CD19-targeting CAR-T cell therapy, covering 2025-06-25 to 2025-06-25. Get the full timeline:
Most recent: Clinical Trial Update: BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B-ALL [Phase 1, Phase 2]